NeuroVive Pharmaceutical AB EPS
What is the EPS of NeuroVive Pharmaceutical AB?
The EPS of NeuroVive Pharmaceutical AB is -0.01
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on OTC compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with eps similar to NeuroVive Pharmaceutical AB
- Yu Tak International has EPS of -0.01
- Solar Alliance has EPS of -0.01
- Sling has EPS of -0.01
- Future Land Development has EPS of -0.01
- 01 Communique Laboratory has EPS of -0.01
- Copper Lake Resources has EPS of -0.01
- NeuroVive Pharmaceutical AB has EPS of -0.01
- Ecolomondo has EPS of -0.01
- Quantify Technology has EPS of -0.01
- Lee Kee has EPS of -0.01
- Greenland Minerals has EPS of -0.01
- TrustBIX has EPS of -0.01
- UBA Investments has EPS of -0.01